ArticleAmerican journal of epidemiology2026
REFINE2: a simplified simulation tool to help epidemiologists evaluate the suitability and sensitivity of effect estimation within user-specified data.
Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Epidemiologists have access to various methods to reduce bias and improve statistical efficiency in effect estimation, from standard multivariable regression to state-of-the-art doubly-robust efficient estimators paired with highly flexible, data-adaptive algorithms ("machine learning"). However, due to numerous assumptions and trade-offs, epidemiologists face practical difficulties in recognizing which method, if any, may be suitable for their specific data and hypotheses. Importantly, relative advantages are necessarily context-specific (data structure, algorithms, model misspecification), limiting the utility of universal guidance. Evaluating performance through real-data-based simulations is useful but out-of-reach for many epidemiologists. We present a user-friendly, offline Shiny app REFINE2 (Realistic Evaluations of Finite sample INference using Efficient Estimators) that enables analysts to input their own data and quickly compare the performance of different algorithms within their data context in estimating a prespecified average treatment effect (ATE). REFINE2 automates plasmode simulation of a plausible target ATE given observed covariates and then examines bias and confidence interval coverage (relative to this target) given user-specified models. We present an extensive case study to illustrate how REFINE2 can be used to guide analyses within epidemiologist's own data under three typical scenarios: residual confounding; spurious covariates; and mis-specified effect modification. As expected, the apparent best method differed across scenarios and are suboptimal under residual confounding. REFINE2 may help epidemiologists not only chose amongst imperfect models, but also better understand common underappreciated problems, such as finite sample bias using machine learning.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.